Korro Bio (KRRO) Return on Invested Capital (2022 - 2023)
Korro Bio's (KRRO) quarterly Return on Invested Capital came in at 0.05% in Q4 2023, down 2.0% YoY from 0.05% in Q4 2022, and down 152.63% on a QoQ basis from 0.02% in Q3 2023.
Korro Bio (KRRO) Return on Invested Capital (2022 - 2023) Analysis & Trends
Korro Bio (KRRO) has 2 years of Return on Invested Capital data on file, last reported at 0.05% in Q4 2023.
- Quarterly Return on Invested Capital fell 2.0% year-over-year to 0.05% in Q4 2023, while the trailing twelve-month figure through Dec 2023 was 0.05% (down 2.0% YoY) and the FY2022 annual result came in at 0.11%, changed N/A from the prior year.
- Return on Invested Capital retreated to 0.05% in Q4 2023, from 0.02% in the prior quarter.
- In the past five years, Return on Invested Capital ranged from a high of 0.02% in Q2 2023 to a low of 0.35% in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 0.04% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -0.17% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 0.00% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 0.00% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.35% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Korro Bio | 231.77 Mn | 116.73 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.05% |
| Sep 30, 2023 | -0.02% |
| Jun 30, 2023 | -0.02% |
| Mar 31, 2023 | -0.02% |
| Dec 31, 2022 | -0.03% |
| Sep 30, 2022 | -0.06% |
| Jun 30, 2022 | -0.13% |
| Mar 31, 2022 | -0.35% |